GeneDx 주식 가격. WGS - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

개인 투자자를 위한 전문가급 도구.

프리미엄

가격

77.3625

매수가

74.30

매도가

77.50

거래량

407,160

74.74 일간 변동폭 79.99

3.26 52주 범위 98.87

market_cap

2.125B

전일 종가

79.24

개장가

78.48

최근 거래 시간

74.75

마지막 거래 시간

06:16:02

재정 규모

US$ 31,274,691

VWAP

76.8118

평균 볼륨(3m)

652,165

발행 주식

27,471,397

배당수익률

주가수익률

-11.82

주당순이익(EPS)

-6.4

매출

202.57M

순이익

-175.77M

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and... GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut. 더 보기

섹터

Blank Checks

산업

Health Services

웹사이트

www.genedx.com

본부

Wilmington, Delaware, USA

설립됨

2020

GeneDx Holdings Corporation is listed in the Blank Checks sector of the 나스닥 with ticker WGS. The last closing price for GeneDx was US$79.24. Over the last year, GeneDx shares have traded in a share price range of US$ 3.26 to US$ 98.87.

GeneDx currently has 27,471,397 shares in issue. The market capitalisation of GeneDx is US$2.18 billion. GeneDx has a price to earnings ratio (PE ratio) of -11.82.

GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced it will release financial results for the fourth quarter 2024 and the full year 2024...

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that, effective as of January 14, 2025, the compensation committee...

GeneDx Announces Preliminary 2024 Financial Results

Expects to exceed guidance with full year 2024 revenues1 of at least $299 million Expects fourth quarter 2024 revenues1 of at least $92 million Expects to exceed guidance with full year 2024...

GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a new way to provide genetic counseling and test-ordering services for patients and...

GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients

Contributed nearly one quarter of all submissions to GeneMatcher and collaborated on more than 85 peer reviewed publications in 2024 GeneDx (Nasdaq: WGS), a leader in delivering improved health...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	2.2025	2.93041511442	75.16	81.8857	73.5	739795	77.35176043	CS
4	0.5525	0.719307381851	76.81	98.87	66.8076	938295	80.70076491	CS
12	0.6555	0.854550432164	76.707	98.87	66	652165	78.02098437	CS
26	43.8225	130.657423971	33.54	98.87	25.84	587362	63.31870506	CS
52	73.9125	2142.39130435	3.45	98.87	3.26	489211	45.78892672	CS
156	66.4395	608.253227135	10.923	98.87	1.16	939903	20.50704519	CS
260	66.4395	608.253227135	10.923	98.87	1.16	939903	20.50704519	CS

WGS - Frequently Asked Questions (FAQ)

What is the current GeneDx share price?

The current share price of GeneDx is US$ 77.3625

How many GeneDx shares are in issue?

GeneDx has 27,471,397 shares in issue

What is the market cap of GeneDx?

The market capitalisation of GeneDx is USD 2.18B

What is the 1 year trading range for GeneDx share price?

GeneDx has traded in the range of US$ 3.26 to US$ 98.87 during the past year

What is the PE ratio of GeneDx?

The price to earnings ratio of GeneDx is -11.82

What is the cash to sales ratio of GeneDx?

The cash to sales ratio of GeneDx is 10.26

What is the reporting currency for GeneDx?

GeneDx reports financial results in USD

What is the latest annual turnover for GeneDx?

The latest annual turnover of GeneDx is USD 202.57M

What is the latest annual profit for GeneDx?

The latest annual profit of GeneDx is USD -175.77M

What is the registered address of GeneDx?

The registered address for GeneDx is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the GeneDx website address?

The website address for GeneDx is www.genedx.com

Which industry sector does GeneDx operate in?

GeneDx operates in the HEALTH SERVICES sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
PCSAProcessa Pharmaceuticals Inc	US$ 0.8626 (45.64%)	479.02k
CARMCarisma Therapeutics Inc	US$ 0.6959 (37.91%)	3.08M
GMHSGamehaus Holdings Inc	US$ 2.50 (30.21%)	48.12k
OSTOstin Technology Group Company Ltd	US$ 3.53 (21.55%)	729.46k
EDSAEdesa Biotech Inc	US$ 2.15 (17.51%)	2.5k
MXLMaxLinear Inc	US$ 18.00 (-17.36%)	57.09k
RFACRF Acquisition Corporation	US$ 5.95 (-14.51%)	353
IKTInhibikase Therapeutics Inc	US$ 2.4201 (-14.18%)	73.39k
DSYBig Tree Cloud Holdings Limited	US$ 1.75 (-10.26%)	1.03k
IFBDInfobird Company Ltd	US$ 1.95 (-10.14%)	160.78k
NVDANVIDIA Corporation	US$ 125.00 (0.98%)	24.18M
VCSHVanguard Short Term Corporate Bond	US$ 78.43 (0.01%)	9.57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 24.8403 (0.81%)	7.28M
TSLATesla Inc	US$ 389.0253 (0.26%)	5.59M
MGOLMGO Global Inc	US$ 0.112199 (10.11%)	4.39M